Terms: = Cervical cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
6 results:
1. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in cervical cancer Patients.
Cao M; Wang Y; Wang D; Duan Y; Hong W; Zhang N; Shah W; Wang Y; Chen H
Am J Clin Pathol; 2020 Mar; 153(4):502-512. PubMed ID: 31819948
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.
Heeren AM; van Luijk IF; Lakeman J; Pocorni N; Kole J; de Menezes RX; Kenter GG; Bosse T; de Kroon CD; Jordanova ES
Cancer Immunol Immunother; 2019 Nov; 68(11):1759-1767. PubMed ID: 31616965
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-infiltrating CD8+ and foxp3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract] [Full Text] [Related]
4. The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome.
Gorter A; Prins F; van Diepen M; Punt S; van der Burg SH
J Transl Med; 2015 Sep; 13():295. PubMed ID: 26357849
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration.
Yu Q; Lou XM; He Y
Med Oncol; 2014 Jan; 31(1):795. PubMed ID: 24310812
[TBL] [Abstract] [Full Text] [Related]
6. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)foxp3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.
Shah W; Yan X; Jing L; Zhou Y; Chen H; Wang Y
Cell Mol Immunol; 2011 Jan; 8(1):59-66. PubMed ID: 21200385
[TBL] [Abstract] [Full Text] [Related]
